Please login to the form below

Not currently logged in
Email:
Password:

ESMO

This page shows the latest ESMO news and features for those working in and with pharma, biotech and healthcare.

Merck closes in on adjuvant melanoma indication for Keytruda

Merck closes in on adjuvant melanoma indication for Keytruda

At last year’s European Society for Medical Oncology (ESMO) congress, Bristol-Myers Squibb’s Opdivo (nivolumab) was found to be more effective than Yervoy (ipilimumab) - BMS’CTLA4 inhibitor which is

Latest news

More from news
Approximately 9 fully matching, plus 20 partially matching documents found.

Latest Intelligence

  • Biologic or biosimilar: what are prescribers thinking? Biologic or biosimilar: what are prescribers thinking?

    independent organisations such as ESMO, which recently published a paper supporting biosimilars as an option for sustainable cancer treatment.

  • Accelerating innovation Accelerating innovation

    Phase II results from its CABOSUN trial, in which it was compared with Sutent in previously untreated advanced RCC, were released at this year’s European Society for Medical Oncology (ESMO) ... As the ESMO meeting began, Ipsen received the news that

  • Charting a course for expansion Charting a course for expansion

    When I met him at the annual European Society for Medical Oncology (ESMO) meeting in Copenhagen last month he explained how international expansion and oncology were key to Ipsen's plans. ... In Copenhagen, Ipsen's ESMO focus was on the CABOSUN study,

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 8 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Makara Health

Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics